Shares of H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Trading Down 0.0 %
The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71. The company has a market cap of $21.91 billion, a P/E ratio of 25.00 and a beta of 0.68. The stock’s 50-day moving average is $22.00 and its two-hundred day moving average is $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Further Reading
- Five stocks we like better than H. Lundbeck A/S
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Top 3 ETFs to Hedge Against Inflation in 2025
- Where to Find Earnings Call Transcripts
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
